On May 29, 2020, the World Health Organization (WHO) announced that thirty countries and multiple international partners and…
On May 28, 2020, the U.S. Dept. of Veterans Affairs (VA) began a national four-year study on the…
On May 28, 2020, Quest Diagnostics announced it had received emergency use authorization (EUA) from the U.S. Food…
On May 28, 2020, Atossa Therapeutics announced that it had begun the development of a second COVID-19 program…
On May 27, 2020, the National Institutes of Health (NIH) announced it had found that molecules released into…
On May 27, 2020, an analyses of the largest publicly available catalog of human genomic data revealed new…
On May 27, 2020, Quest Diagnostics launched a new suite of Return to Work services built around large-scale…
On May 26, 2020, the U.S. Food and Drug Administration (FDA) announced it had approved Amivas’ artesunate for…
On May 26, 2020, Royal Philips announced it had received 510(k) clearance from the FDA for its wearable…
On May 26, 2020, GenScript Biotech announced that it had obtained CE-IVD for its SARS-CoV-2 diagnostic products to…
On May 26, 2020, Todos Medical announced that it had entered into a cross-distribution agreement with L1 Systems, Ltd., a…
On May 26, 2020, Meridian Bioscience announced that its SARS-CoV-2 antigens and related reagents are part of assays…
On May 21, 2020, Abbott announced an interim analysis of an ongoing multi-site clinical study in urgent care…
On May 21, 2020, bioMerieux announced the CE marking of VIDAS® anti-SARS-CoV-2 serology tests to detect antibodies in people…
On May 21, 2020, the BioProducts Institute at the University of British Columbia announced it had designed a…
On May 21, 2020, Roche announced that it has acquired Stratos Genomics, an early-stage sequencing technology company to…
On May 21, 2020, the U.S. Food and Drug Administration (FDA) posted list of antibody tests removed from…
On May 20, 2020, Mammoth Biosciences announced a collaboration with GSK Consumer Healthcare to develop an accurate, easy-to-use,…
On May 20, 2020, Atossa Therapeutics announced the successful results from in vitro testing of AT-H201, Atossa’s proprietary COVID-19 drug…
On May 19, 2020, the National Institutes of Health (NIH) reported that researchers from the University of Texas,…
On May 19, 2020, a University of Southern California (USC) study reported results from the first phase of…
On May 19, 2020, Bio-Techne and the Mount Sinai Health System in New York, through its commercial affiliate…
On May 19, 2020, Roche announced its Elecsys Anti-SARS-CoV-2 antibody test is live at more than 20 commercial…
On May 18, 2020, the National Institutes of Health (NIH) reported that roughly 3 to 5% of children…
On May 18, 2020, Quidel announced it had received Emergency Use Authorization (EUA) for the Lyra Direct SARS-CoV-2…
On May 18, 2020, Thermo Fisher Scientific announced it had received a contract from the U.S. government to…
On May 18, 2020, Todos Medical announced its first commercial sale of COVID-19 tests. The sale was made…
On May 15, 2020, Duke-NUS Medical School, GenScript Biotech, and the Diagnostics Development Hub at Singapore’s Agency for…
On May 15, 2020, Hologic announced it had received Emergency Use Authorization (EUA) from the U.S. Food and Drug…
On May 14, 2020, the U.S. Food and Drug Administration (FDA) alerted the public to early data that…